AbbVie Presents Optimistic Take For 2020, Expects Quick Recovery For Botox Aesthetic

 
• By Joseph Haas

AbbVie made only a slight adjustment to its earnings-per-share guidance despite expected Q2 downturn due to the pandemic. It sees Allergan’s aesthetic business as bouncing back quickly.

Stone / United Kingdom - February 12 2020: Abbvie biopharmaceutical company logo seen on the brochure with the viral masks, syringe and pills. Concept photo. Selective focus.
AbbVie says its merger with Allergan likely will close in May

More from Earnings

More from Business